Factors associated with children's health facility visits for primaquine treatment in rural Papua New Guinea
To control and eventually eliminate vivax malaria, radical treatment with primaquine (PQ) is essential after completion of blood-stage treatment. Although in many malaria-endemic countries, village health volunteers (VHVs) are engaged in diagnostic treatment of malaria in remote communities, they pr...
Saved in:
Published in | Malaria journal Vol. 18; no. 1; p. 42 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central Ltd
20.02.2019
BioMed Central BMC |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | To control and eventually eliminate vivax malaria, radical treatment with primaquine (PQ) is essential after completion of blood-stage treatment. Although in many malaria-endemic countries, village health volunteers (VHVs) are engaged in diagnostic treatment of malaria in remote communities, they principally provide blood-stage treatment. In such a situation, access to PQ following blood-stage treatment can be a barrier to complete treatment. However, studies on access to PQ treatment have been scarce and limited in health facility-based settings. This study aimed to identify factors associated with access to PQ treatment in rural Papua New Guinea (PNG) from the community case management perspective.
A community-based, cross-sectional survey was conducted to collect sociodemographic information on children under 15 years of age, their households, and their caretakers in East Sepik Province, PNG. Data collection lasted from February to March, 2015. Information on the diagnoses of potential non-falciparum malaria and prescription of PQ in preceding year (January to December 2014) were obtained from child health-record books. Then, multilevel logistic regression model was used to determine the factors associated with formal health facility visits for PQ treatment among children with potential non-falciparum malaria.
Of 420 episodes diagnosed as potential non-falciparum malaria, 46 (11%) were immediately given PQ. The rest were instructed to visit formal health facilities (HFs) for PQ, and the patients obtained PQ during the second visit to HFs was 44%. Consequently, the overall proportion of PQ prescription was 50%. Logistic regression analysis suggested that among the patients who were instructed to visit HFs for PQ treatment, the initial visit to VHV and higher transportation costs to HF were inversely associated with PQ prescription during the second visit to an HF.
Few children received PQ treatment during the second visit to HFs following diagnosis of potential non-falciparum malaria. These findings suggest a need to establish a policy to reduce structural and economic barriers and improve rural inhabitant access to PQ treatment. |
---|---|
AbstractList | To control and eventually eliminate vivax malaria, radical treatment with primaquine (PQ) is essential after completion of blood-stage treatment. Although in many malaria-endemic countries, village health volunteers (VHVs) are engaged in diagnostic treatment of malaria in remote communities, they principally provide blood-stage treatment. In such a situation, access to PQ following blood-stage treatment can be a barrier to complete treatment. However, studies on access to PQ treatment have been scarce and limited in health facility-based settings. This study aimed to identify factors associated with access to PQ treatment in rural Papua New Guinea (PNG) from the community case management perspective. A community-based, cross-sectional survey was conducted to collect sociodemographic information on children under 15 years of age, their households, and their caretakers in East Sepik Province, PNG. Data collection lasted from February to March, 2015. Information on the diagnoses of potential non-falciparum malaria and prescription of PQ in preceding year (January to December 2014) were obtained from child health-record books. Then, multilevel logistic regression model was used to determine the factors associated with formal health facility visits for PQ treatment among children with potential non-falciparum malaria. Of 420 episodes diagnosed as potential non-falciparum malaria, 46 (11%) were immediately given PQ. The rest were instructed to visit formal health facilities (HFs) for PQ, and the patients obtained PQ during the second visit to HFs was 44%. Consequently, the overall proportion of PQ prescription was 50%. Logistic regression analysis suggested that among the patients who were instructed to visit HFs for PQ treatment, the initial visit to VHV and higher transportation costs to HF were inversely associated with PQ prescription during the second visit to an HF. Few children received PQ treatment during the second visit to HFs following diagnosis of potential non-falciparum malaria. These findings suggest a need to establish a policy to reduce structural and economic barriers and improve rural inhabitant access to PQ treatment. To control and eventually eliminate vivax malaria, radical treatment with primaquine (PQ) is essential after completion of blood-stage treatment. Although in many malaria-endemic countries, village health volunteers (VHVs) are engaged in diagnostic treatment of malaria in remote communities, they principally provide blood-stage treatment. In such a situation, access to PQ following blood-stage treatment can be a barrier to complete treatment. However, studies on access to PQ treatment have been scarce and limited in health facility-based settings. This study aimed to identify factors associated with access to PQ treatment in rural Papua New Guinea (PNG) from the community case management perspective. A community-based, cross-sectional survey was conducted to collect sociodemographic information on children under 15 years of age, their households, and their caretakers in East Sepik Province, PNG. Data collection lasted from February to March, 2015. Information on the diagnoses of potential non-falciparum malaria and prescription of PQ in preceding year (January to December 2014) were obtained from child health-record books. Then, multilevel logistic regression model was used to determine the factors associated with formal health facility visits for PQ treatment among children with potential non-falciparum malaria. Of 420 episodes diagnosed as potential non-falciparum malaria, 46 (11%) were immediately given PQ. The rest were instructed to visit formal health facilities (HFs) for PQ, and the patients obtained PQ during the second visit to HFs was 44%. Consequently, the overall proportion of PQ prescription was 50%. Logistic regression analysis suggested that among the patients who were instructed to visit HFs for PQ treatment, the initial visit to VHV and higher transportation costs to HF were inversely associated with PQ prescription during the second visit to an HF. Few children received PQ treatment during the second visit to HFs following diagnosis of potential non-falciparum malaria. These findings suggest a need to establish a policy to reduce structural and economic barriers and improve rural inhabitant access to PQ treatment. Abstract Background To control and eventually eliminate vivax malaria, radical treatment with primaquine (PQ) is essential after completion of blood-stage treatment. Although in many malaria-endemic countries, village health volunteers (VHVs) are engaged in diagnostic treatment of malaria in remote communities, they principally provide blood-stage treatment. In such a situation, access to PQ following blood-stage treatment can be a barrier to complete treatment. However, studies on access to PQ treatment have been scarce and limited in health facility-based settings. This study aimed to identify factors associated with access to PQ treatment in rural Papua New Guinea (PNG) from the community case management perspective. Methods A community-based, cross-sectional survey was conducted to collect sociodemographic information on children under 15 years of age, their households, and their caretakers in East Sepik Province, PNG. Data collection lasted from February to March, 2015. Information on the diagnoses of potential non-falciparum malaria and prescription of PQ in preceding year (January to December 2014) were obtained from child health-record books. Then, multilevel logistic regression model was used to determine the factors associated with formal health facility visits for PQ treatment among children with potential non-falciparum malaria. Results Of 420 episodes diagnosed as potential non-falciparum malaria, 46 (11%) were immediately given PQ. The rest were instructed to visit formal health facilities (HFs) for PQ, and the patients obtained PQ during the second visit to HFs was 44%. Consequently, the overall proportion of PQ prescription was 50%. Logistic regression analysis suggested that among the patients who were instructed to visit HFs for PQ treatment, the initial visit to VHV and higher transportation costs to HF were inversely associated with PQ prescription during the second visit to an HF. Conclusions Few children received PQ treatment during the second visit to HFs following diagnosis of potential non-falciparum malaria. These findings suggest a need to establish a policy to reduce structural and economic barriers and improve rural inhabitant access to PQ treatment. Background To control and eventually eliminate vivax malaria, radical treatment with primaquine (PQ) is essential after completion of blood-stage treatment. Although in many malaria-endemic countries, village health volunteers (VHVs) are engaged in diagnostic treatment of malaria in remote communities, they principally provide blood-stage treatment. In such a situation, access to PQ following blood-stage treatment can be a barrier to complete treatment. However, studies on access to PQ treatment have been scarce and limited in health facility-based settings. This study aimed to identify factors associated with access to PQ treatment in rural Papua New Guinea (PNG) from the community case management perspective. Methods A community-based, cross-sectional survey was conducted to collect sociodemographic information on children under 15 years of age, their households, and their caretakers in East Sepik Province, PNG. Data collection lasted from February to March, 2015. Information on the diagnoses of potential non-falciparum malaria and prescription of PQ in preceding year (January to December 2014) were obtained from child health-record books. Then, multilevel logistic regression model was used to determine the factors associated with formal health facility visits for PQ treatment among children with potential non-falciparum malaria. Results Of 420 episodes diagnosed as potential non-falciparum malaria, 46 (11%) were immediately given PQ. The rest were instructed to visit formal health facilities (HFs) for PQ, and the patients obtained PQ during the second visit to HFs was 44%. Consequently, the overall proportion of PQ prescription was 50%. Logistic regression analysis suggested that among the patients who were instructed to visit HFs for PQ treatment, the initial visit to VHV and higher transportation costs to HF were inversely associated with PQ prescription during the second visit to an HF. Conclusions Few children received PQ treatment during the second visit to HFs following diagnosis of potential non-falciparum malaria. These findings suggest a need to establish a policy to reduce structural and economic barriers and improve rural inhabitant access to PQ treatment. Keywords: Antimalarials, Therapeutic uses, Child, Vivax malaria, Continuity of patient care, Health service accessibility, Patient compliance, Patient acceptance of health care, Appointments and schedules Background To control and eventually eliminate vivax malaria, radical treatment with primaquine (PQ) is essential after completion of blood-stage treatment. Although in many malaria-endemic countries, village health volunteers (VHVs) are engaged in diagnostic treatment of malaria in remote communities, they principally provide blood-stage treatment. In such a situation, access to PQ following blood-stage treatment can be a barrier to complete treatment. However, studies on access to PQ treatment have been scarce and limited in health facility-based settings. This study aimed to identify factors associated with access to PQ treatment in rural Papua New Guinea (PNG) from the community case management perspective. Methods A community-based, cross-sectional survey was conducted to collect sociodemographic information on children under 15 years of age, their households, and their caretakers in East Sepik Province, PNG. Data collection lasted from February to March, 2015. Information on the diagnoses of potential non-falciparum malaria and prescription of PQ in preceding year (January to December 2014) were obtained from child health-record books. Then, multilevel logistic regression model was used to determine the factors associated with formal health facility visits for PQ treatment among children with potential non-falciparum malaria. Results Of 420 episodes diagnosed as potential non-falciparum malaria, 46 (11%) were immediately given PQ. The rest were instructed to visit formal health facilities (HFs) for PQ, and the patients obtained PQ during the second visit to HFs was 44%. Consequently, the overall proportion of PQ prescription was 50%. Logistic regression analysis suggested that among the patients who were instructed to visit HFs for PQ treatment, the initial visit to VHV and higher transportation costs to HF were inversely associated with PQ prescription during the second visit to an HF. Conclusions Few children received PQ treatment during the second visit to HFs following diagnosis of potential non-falciparum malaria. These findings suggest a need to establish a policy to reduce structural and economic barriers and improve rural inhabitant access to PQ treatment. BACKGROUNDTo control and eventually eliminate vivax malaria, radical treatment with primaquine (PQ) is essential after completion of blood-stage treatment. Although in many malaria-endemic countries, village health volunteers (VHVs) are engaged in diagnostic treatment of malaria in remote communities, they principally provide blood-stage treatment. In such a situation, access to PQ following blood-stage treatment can be a barrier to complete treatment. However, studies on access to PQ treatment have been scarce and limited in health facility-based settings. This study aimed to identify factors associated with access to PQ treatment in rural Papua New Guinea (PNG) from the community case management perspective.METHODSA community-based, cross-sectional survey was conducted to collect sociodemographic information on children under 15 years of age, their households, and their caretakers in East Sepik Province, PNG. Data collection lasted from February to March, 2015. Information on the diagnoses of potential non-falciparum malaria and prescription of PQ in preceding year (January to December 2014) were obtained from child health-record books. Then, multilevel logistic regression model was used to determine the factors associated with formal health facility visits for PQ treatment among children with potential non-falciparum malaria.RESULTSOf 420 episodes diagnosed as potential non-falciparum malaria, 46 (11%) were immediately given PQ. The rest were instructed to visit formal health facilities (HFs) for PQ, and the patients obtained PQ during the second visit to HFs was 44%. Consequently, the overall proportion of PQ prescription was 50%. Logistic regression analysis suggested that among the patients who were instructed to visit HFs for PQ treatment, the initial visit to VHV and higher transportation costs to HF were inversely associated with PQ prescription during the second visit to an HF.CONCLUSIONSFew children received PQ treatment during the second visit to HFs following diagnosis of potential non-falciparum malaria. These findings suggest a need to establish a policy to reduce structural and economic barriers and improve rural inhabitant access to PQ treatment. |
ArticleNumber | 42 |
Audience | Academic |
Author | Furusawa, Takuro Yoshii, Akiko Tsukahara, Takahiro Sekihara, Makoto Hombhanje, Francis |
Author_xml | – sequence: 1 givenname: Akiko surname: Yoshii fullname: Yoshii, Akiko organization: Department of International Affairs and Tropical Medicine, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, 162-8666, Japan – sequence: 2 givenname: Makoto surname: Sekihara fullname: Sekihara, Makoto organization: Department of Tropical Medicine and Parasitology, Juntendo University School of Medicine, 6th Floor, Bldg. No.9, 2-1-1, Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan – sequence: 3 givenname: Takuro surname: Furusawa fullname: Furusawa, Takuro organization: Department of Ecology and Environment, Graduate School of Asian and African Area Studies, Kyoto University, Room#AA431, Research Bldg. No.2, Yoshida-Honmachi, Sakyo-ku, Kyoto, 606-8501, Japan – sequence: 4 givenname: Francis surname: Hombhanje fullname: Hombhanje, Francis organization: Centre for Health Research and Diagnostics, Divine Word University-Rabaul Campus, Kokopo, Papua New Guinea – sequence: 5 givenname: Takahiro orcidid: 0000-0002-4086-794X surname: Tsukahara fullname: Tsukahara, Takahiro email: tsukahara.takahiro@twmu.ac.jp, tsukahara.takahiro@twmu.ac.jp organization: School of Economics, Hosei University Graduate School, 2-15-2 Ichigaya Tamachi, Shinjuku-ku, Tokyo, 162-0843, Japan. tsukahara.takahiro@twmu.ac.jp |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30786891$$D View this record in MEDLINE/PubMed |
BookMark | eNptUk1v1DAUjFAR_YAfwAVZ4gCXFH_HuSBVFS2VKuAAZ-vFsXe9SuKt7bTqv8fpltJFyAc_jeeN3zzNcXUwhclW1VuCTwlR8lMitGWyxqStqWxEzV9UR4SXgqpGHDyrD6vjlDYYk0Y19FV1yHCjpGrJUTVcgMkhJgQpBeMh2x7d-bxGZu2HPtrpQ0JrC0NBHBg_-HyPbn3yOSEXItpGP8LN7CeLcrSQRztl5CcU5wgD-gHbGdA3e4cuFwq8rl46GJJ983ifVL8uvvw8_1pff7-8Oj-7ro2QONeUU4Ubh3tsjGgZUIKLPScEVT2VrOu6RlGnLDguZYsJw50ThAPmYBRRnJ1UVzvdPsBGP8wY73UArx-AEFcaYvZmsLq30ANpDesw4YTzrm-lbIwkHXe8FU3R-rzT2s7daHtTDBZre6L7L5Nf61W41ZIpRhtRBD4-CsRwM9uU9eiTscMAkw1z0rRMLJgQChfq-3-omzDHqayqsFrGKZeM_2WtoBjwkwvlX7OI6jOhCGsxF7SwTv_DKqe3ozclR84XfK-B7BpMDClF6548EqyXuOld3HSJm17ippdR3j1fzlPHn3yx3-iu0NY |
CitedBy_id | crossref_primary_10_1186_s12889_021_11602_1 |
Cites_doi | 10.1056/NEJMoa0804915 10.1016/S0277-9536(01)00036-3 10.1186/1475-2875-11-63 10.1016/j.ijpara.2016.06.006 10.3389/fpubh.2015.00275 10.1093/trstmh/try003 10.1371/journal.pone.0009047 10.1371/journal.pntd.0006230 10.1186/1475-2875-13-488 10.1186/s41182-016-0008-7 10.1093/heapol/czl029 10.4269/ajtmh.2007.77.947 10.1186/1475-2875-9-308 10.1093/ije/dys037 10.3329/jhpn.v27i1.3313 10.1186/1475-2875-9-347 10.1186/1475-2875-7-75 10.1186/1475-2875-8-41 10.1186/1475-2875-10-355 10.1046/j.1365-3156.2003.01030.x 10.1186/1475-2875-12-433 10.1007/s10461-009-9533-2 10.1097/QAI.0000000000000315 10.1371/journal.pone.0040183 10.1186/1471-2458-9-85 10.1590/0037-8682-0275-2015 10.2149/tmh.2008-13 10.1371/journal.pone.0000121 10.4269/ajtmh.2010.09-0521 10.1186/1475-2875-14-1 10.1186/s12936-017-1784-1 10.1186/1475-2875-8-118 10.1186/1475-2875-9-320 10.1093/infdis/80.3.237 10.1186/s12936-016-1588-8 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2019 BioMed Central Ltd. Copyright © 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s) 2019 |
Copyright_xml | – notice: COPYRIGHT 2019 BioMed Central Ltd. – notice: Copyright © 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s) 2019 |
DBID | NPM AAYXX CITATION 3V. 7SS 7U9 7X7 7XB 88E 8C1 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR C1K CCPQU DWQXO F1W FYUFA GHDGH H94 H95 H97 K9. L.G M0S M1P M7N PIMPY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
DOI | 10.1186/s12936-019-2675-4 |
DatabaseName | PubMed CrossRef ProQuest Central (Corporate) Entomology Abstracts (Full archive) Virology and AIDS Abstracts Health & Medical Collection (Proquest) ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Public Health Database (Proquest) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials AUTh Library subscriptions: ProQuest Central Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Central ASFA: Aquatic Sciences and Fisheries Abstracts Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts Aquatic Science & Fisheries Abstracts (ASFA) 1: Biological Sciences & Living Resources Aquatic Science & Fisheries Abstracts (ASFA) 3: Aquatic Pollution & Environmental Quality ProQuest Health & Medical Complete (Alumni) Aquatic Science & Fisheries Abstracts (ASFA) Professional Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) Algology Mycology and Protozoology Abstracts (Microbiology C) Publicly Available Content Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | PubMed CrossRef Publicly Available Content Database Aquatic Science & Fisheries Abstracts (ASFA) Professional ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Central China Aquatic Science & Fisheries Abstracts (ASFA) 3: Aquatic Pollution & Environmental Quality Environmental Sciences and Pollution Management ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Algology Mycology and Protozoology Abstracts (Microbiology C) AIDS and Cancer Research Abstracts Aquatic Science & Fisheries Abstracts (ASFA) 1: Biological Sciences & Living Resources ProQuest Medical Library (Alumni) ProQuest Public Health Virology and AIDS Abstracts ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Entomology Abstracts ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ASFA: Aquatic Sciences and Fisheries Abstracts ProQuest One Academic ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | PubMed Publicly Available Content Database MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: BENPR name: AUTh Library subscriptions: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Public Health Economics |
EISSN | 1475-2875 |
EndPage | 42 |
ExternalDocumentID | oai_doaj_org_article_deada19c3b014144bd9667c61b4f4957 A581390452 10_1186_s12936_019_2675_4 30786891 |
Genre | Journal Article |
GeographicLocations | Papua New Guinea Asia Africa |
GeographicLocations_xml | – name: Papua New Guinea – name: Africa – name: Asia |
GrantInformation_xml | – fundername: JSPS KAKENHI grantid: JP25305023 – fundername: ; grantid: JP25305023 – fundername: ; |
GroupedDBID | --- -A0 0R~ 29M 2WC 3V. 53G 5VS 7X7 88E 8C1 8FI 8FJ AAFWJ AAJSJ ABDBF ABUWG ACGFO ACGFS ACIHN ACMJI ACPRK ACRMQ ADBBV ADINQ ADRAZ ADUKV AEAQA AENEX AFKRA AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C24 C6C CCPQU CS3 DIK DU5 E3Z EAD EAP EAS EBD EBLON EBS ECGQY EJD EMB EMK EMOBN ESX F5P FRP FYUFA GROUPED_DOAJ GX1 H13 HMCUK HYE IAO IHR INH INR ITC KQ8 M1P M48 M~E NPM O5R O5S OK1 P2P PGMZT PIMPY PQQKQ PROAC PSQYO RBZ RNS ROL RPM RSV SBL SOJ SV3 TR2 TUS U2A UKHRP W2D WOQ WOW XSB AAYXX AFPKN CITATION ABVAZ AFGXO AFNRJ 7SS 7U9 7XB 8FK AZQEC C1K DWQXO F1W H94 H95 H97 K9. L.G M7N PQEST PQUKI PRINS 7X8 5PM |
ID | FETCH-LOGICAL-c560t-242807f0d0cc593a210267f5528d263bbb782f8eaf46690130bf514a04ac81843 |
IEDL.DBID | RPM |
ISSN | 1475-2875 |
IngestDate | Tue Oct 22 15:14:25 EDT 2024 Tue Sep 17 21:18:04 EDT 2024 Fri Oct 25 11:32:22 EDT 2024 Thu Oct 10 17:48:29 EDT 2024 Fri Feb 23 00:11:15 EST 2024 Fri Feb 02 04:29:06 EST 2024 Thu Sep 12 19:25:07 EDT 2024 Wed Oct 16 00:50:52 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Continuity of patient care Health service accessibility Patient acceptance of health care Antimalarials Therapeutic uses Appointments and schedules Child Patient compliance Vivax malaria |
Language | English |
License | Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c560t-242807f0d0cc593a210267f5528d263bbb782f8eaf46690130bf514a04ac81843 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0002-4086-794X |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6383275/ |
PMID | 30786891 |
PQID | 2193424634 |
PQPubID | 42600 |
PageCount | 1 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_deada19c3b014144bd9667c61b4f4957 pubmedcentral_primary_oai_pubmedcentral_nih_gov_6383275 proquest_miscellaneous_2184535580 proquest_journals_2193424634 gale_infotracmisc_A581390452 gale_infotracacademiconefile_A581390452 crossref_primary_10_1186_s12936_019_2675_4 pubmed_primary_30786891 |
PublicationCentury | 2000 |
PublicationDate | 2019-02-20 |
PublicationDateYYYYMMDD | 2019-02-20 |
PublicationDate_xml | – month: 02 year: 2019 text: 2019-02-20 day: 20 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London |
PublicationTitle | Malaria journal |
PublicationTitleAlternate | Malar J |
PublicationYear | 2019 |
Publisher | BioMed Central Ltd BioMed Central BMC |
Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
References | Y Inoue (2675_CR28) 2017; 111 U Haque (2675_CR9) 2012; 11 N Khantikul (2675_CR8) 2009; 27 J Recht (2675_CR47) 2018; 12 A Getahun (2675_CR42) 2010; 9 V Phommanivong (2675_CR14) 2010; 9 LK Das (2675_CR18) 2008; 7 DM Tuller (2675_CR44) 2010; 14 B Genton (2675_CR29) 2005; 48 R Takeuchi (2675_CR5) 2010; 9 A Souares (2675_CR6) 2009; 8 J Marfurt (2675_CR30) 2007; 77 N Hung (2675_CR45) 2008; 36 T Tsukahara (2675_CR15) 2015; 3 Papua New Guinea National Department of Health (2675_CR33) 2003 M Karyana (2675_CR23) 2016; 15 TN Nissen (2675_CR48) 2012; 7 R Zachariah (2675_CR49) 2006; 1 S Vyas (2675_CR37) 2006; 21 WHO (2675_CR35) 2015 KP Grietens (2675_CR22) 2010; 82 HE Ashwell (2675_CR27) 2009; 9 2675_CR19 WHO (2675_CR2) 2017 T Tanahashi (2675_CR53) 1978; 56 2675_CR13 D O'Keefe (2675_CR26) 2011; 54 2675_CR12 2675_CR11 CM Whorton (2675_CR50) 1947; 80 2675_CR10 2675_CR51 J Pulford (2675_CR24) 2013; 12 Divine Word University (2675_CR34) 2010 E Lin (2675_CR21) 2010; 5 MM Thandar (2675_CR41) 2015; 14 P Yenchitsomanus (2675_CR46) 1986; 29 ED Almeida (2675_CR7) 2016; 49 Papua New Guinea National Department of Health (2675_CR32) 2009 HA Karunajeewa (2675_CR31) 2008; 359 RJ Ingram (2675_CR52) 2014; 13 WHO (2675_CR1) 2015 EA Pereira (2675_CR38) 2011; 10 EL Matsumoto-Takahashi (2675_CR16) 2016; 44 O Müller (2675_CR40) 2003; 8 M Morrow (2675_CR17) 2009; 9 K Thriemer (2675_CR4) 2017; 16 2675_CR25 JK Baird (2675_CR3) 2017; 47 IK Nyamongo (2675_CR39) 2002; 54 I Mueller (2675_CR20) 2009; 8 LA Sowah (2675_CR43) 2014; 67 LD Howe (2675_CR36) 2012; 41 |
References_xml | – volume: 359 start-page: 2545 year: 2008 ident: 2675_CR31 publication-title: N Engl J Med doi: 10.1056/NEJMoa0804915 contributor: fullname: HA Karunajeewa – volume-title: Guidelines for the treatment of malaria year: 2015 ident: 2675_CR35 contributor: fullname: WHO – volume: 54 start-page: 377 year: 2002 ident: 2675_CR39 publication-title: Soc Sci Med doi: 10.1016/S0277-9536(01)00036-3 contributor: fullname: IK Nyamongo – volume: 29 start-page: 53 year: 1986 ident: 2675_CR46 publication-title: P N G Med J contributor: fullname: P Yenchitsomanus – ident: 2675_CR51 – volume: 11 start-page: 63 year: 2012 ident: 2675_CR9 publication-title: Malar J doi: 10.1186/1475-2875-11-63 contributor: fullname: U Haque – ident: 2675_CR13 – volume: 47 start-page: 371 year: 2017 ident: 2675_CR3 publication-title: Int J Parasitol doi: 10.1016/j.ijpara.2016.06.006 contributor: fullname: JK Baird – volume: 3 start-page: 275 year: 2015 ident: 2675_CR15 publication-title: Front Public Health. doi: 10.3389/fpubh.2015.00275 contributor: fullname: T Tsukahara – volume: 111 start-page: 490 year: 2017 ident: 2675_CR28 publication-title: Trans R Soc Trop Med Hyg doi: 10.1093/trstmh/try003 contributor: fullname: Y Inoue – volume: 5 start-page: e9047 year: 2010 ident: 2675_CR21 publication-title: PLoS ONE doi: 10.1371/journal.pone.0009047 contributor: fullname: E Lin – ident: 2675_CR10 – volume: 12 start-page: e0006230 year: 2018 ident: 2675_CR47 publication-title: PLoS Negl Trop Dis. doi: 10.1371/journal.pntd.0006230 contributor: fullname: J Recht – volume: 13 start-page: 488 year: 2014 ident: 2675_CR52 publication-title: Malar J doi: 10.1186/1475-2875-13-488 contributor: fullname: RJ Ingram – volume: 56 start-page: 295 year: 1978 ident: 2675_CR53 publication-title: Bull World Health Organ contributor: fullname: T Tanahashi – volume: 44 start-page: 10 year: 2016 ident: 2675_CR16 publication-title: Trop Med Health. doi: 10.1186/s41182-016-0008-7 contributor: fullname: EL Matsumoto-Takahashi – volume: 21 start-page: 459 year: 2006 ident: 2675_CR37 publication-title: Health Policy Plan doi: 10.1093/heapol/czl029 contributor: fullname: S Vyas – volume-title: Malaria diagnosis and the new treatment protocol, a training manual for health workers in Papua New Guinea year: 2010 ident: 2675_CR34 contributor: fullname: Divine Word University – volume: 9 start-page: 1219 year: 2009 ident: 2675_CR27 publication-title: Rural Remote Health. contributor: fullname: HE Ashwell – volume: 77 start-page: 947 year: 2007 ident: 2675_CR30 publication-title: Am J Trop Med Hyg. doi: 10.4269/ajtmh.2007.77.947 contributor: fullname: J Marfurt – volume: 9 start-page: 308 year: 2010 ident: 2675_CR5 publication-title: Malar J doi: 10.1186/1475-2875-9-308 contributor: fullname: R Takeuchi – volume: 41 start-page: 871 year: 2012 ident: 2675_CR36 publication-title: Int J Epidemiol doi: 10.1093/ije/dys037 contributor: fullname: LD Howe – volume: 27 start-page: 4 year: 2009 ident: 2675_CR8 publication-title: J Health Popul Nutr doi: 10.3329/jhpn.v27i1.3313 contributor: fullname: N Khantikul – volume: 48 start-page: 141 year: 2005 ident: 2675_CR29 publication-title: P N G Med J contributor: fullname: B Genton – volume: 9 start-page: 347 year: 2010 ident: 2675_CR14 publication-title: Malar J doi: 10.1186/1475-2875-9-347 contributor: fullname: V Phommanivong – ident: 2675_CR11 – volume: 7 start-page: 75 year: 2008 ident: 2675_CR18 publication-title: Malar J doi: 10.1186/1475-2875-7-75 contributor: fullname: LK Das – volume-title: Standard treatment for common illness of adults in Papua New Guinea: a manual for nurses, community health workers, health extension officers and doctors year: 2003 ident: 2675_CR33 contributor: fullname: Papua New Guinea National Department of Health – volume: 8 start-page: 41 year: 2009 ident: 2675_CR20 publication-title: Malar J doi: 10.1186/1475-2875-8-41 contributor: fullname: I Mueller – volume: 10 start-page: 355 year: 2011 ident: 2675_CR38 publication-title: Malar J doi: 10.1186/1475-2875-10-355 contributor: fullname: EA Pereira – volume: 8 start-page: 290 year: 2003 ident: 2675_CR40 publication-title: Trop Med Int Health. doi: 10.1046/j.1365-3156.2003.01030.x contributor: fullname: O Müller – volume: 12 start-page: 433 year: 2013 ident: 2675_CR24 publication-title: Malar J doi: 10.1186/1475-2875-12-433 contributor: fullname: J Pulford – volume-title: Control and elimination of Plasmodium vivax: a technical brief year: 2015 ident: 2675_CR1 contributor: fullname: WHO – ident: 2675_CR19 – volume: 14 start-page: 778 year: 2010 ident: 2675_CR44 publication-title: AIDS Behav doi: 10.1007/s10461-009-9533-2 contributor: fullname: DM Tuller – ident: 2675_CR25 – volume: 67 start-page: e123 year: 2014 ident: 2675_CR43 publication-title: J Acquir Immune Defic Syndr doi: 10.1097/QAI.0000000000000315 contributor: fullname: LA Sowah – volume: 7 start-page: e40183 year: 2012 ident: 2675_CR48 publication-title: PLoS ONE doi: 10.1371/journal.pone.0040183 contributor: fullname: TN Nissen – volume: 9 start-page: 85 year: 2009 ident: 2675_CR17 publication-title: BMC Public Health. doi: 10.1186/1471-2458-9-85 contributor: fullname: M Morrow – volume: 49 start-page: 248 year: 2016 ident: 2675_CR7 publication-title: Rev Soc Bras Med Trop doi: 10.1590/0037-8682-0275-2015 contributor: fullname: ED Almeida – volume: 36 start-page: 163 year: 2008 ident: 2675_CR45 publication-title: Trop Med Health. doi: 10.2149/tmh.2008-13 contributor: fullname: N Hung – ident: 2675_CR12 – volume: 54 start-page: 147 year: 2011 ident: 2675_CR26 publication-title: PNG Med J. contributor: fullname: D O'Keefe – volume: 1 start-page: e121 year: 2006 ident: 2675_CR49 publication-title: PLoS ONE doi: 10.1371/journal.pone.0000121 contributor: fullname: R Zachariah – volume-title: National malaria treatment policy year: 2009 ident: 2675_CR32 contributor: fullname: Papua New Guinea National Department of Health – volume-title: World malaria report year: 2017 ident: 2675_CR2 contributor: fullname: WHO – volume: 82 start-page: 1017 year: 2010 ident: 2675_CR22 publication-title: Am J Trop Med Hyg. doi: 10.4269/ajtmh.2010.09-0521 contributor: fullname: KP Grietens – volume: 14 start-page: 1 year: 2015 ident: 2675_CR41 publication-title: Malar J doi: 10.1186/1475-2875-14-1 contributor: fullname: MM Thandar – volume: 16 start-page: 141 year: 2017 ident: 2675_CR4 publication-title: Malar J doi: 10.1186/s12936-017-1784-1 contributor: fullname: K Thriemer – volume: 8 start-page: 118 year: 2009 ident: 2675_CR6 publication-title: Malar J doi: 10.1186/1475-2875-8-118 contributor: fullname: A Souares – volume: 9 start-page: 320 year: 2010 ident: 2675_CR42 publication-title: Malar J doi: 10.1186/1475-2875-9-320 contributor: fullname: A Getahun – volume: 80 start-page: 237 year: 1947 ident: 2675_CR50 publication-title: J Infect Dis doi: 10.1093/infdis/80.3.237 contributor: fullname: CM Whorton – volume: 15 start-page: 536 year: 2016 ident: 2675_CR23 publication-title: Malar J doi: 10.1186/s12936-016-1588-8 contributor: fullname: M Karyana |
SSID | ssj0017872 |
Score | 2.2760553 |
Snippet | To control and eventually eliminate vivax malaria, radical treatment with primaquine (PQ) is essential after completion of blood-stage treatment. Although in... Background To control and eventually eliminate vivax malaria, radical treatment with primaquine (PQ) is essential after completion of blood-stage treatment.... BACKGROUNDTo control and eventually eliminate vivax malaria, radical treatment with primaquine (PQ) is essential after completion of blood-stage treatment.... Abstract Background To control and eventually eliminate vivax malaria, radical treatment with primaquine (PQ) is essential after completion of blood-stage... |
SourceID | doaj pubmedcentral proquest gale crossref pubmed |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | 42 |
SubjectTerms | Access Analysis Antimalarials Blood Case management Child Child health Children Childrens health Continuity of patient care Data collection Dehydrogenases Diagnosis Drug therapy Economics Epidemiology Glucose Health facilities Health service accessibility Health services Households Human diseases Malaria Medical diagnosis Medical treatment Patient compliance Patients Policies Primaquine Principal components analysis Regression analysis Rural areas Studies Surveying Therapeutic uses Transportation Tuberculosis Vector-borne diseases Vivax malaria |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NaxQxFA-lp0IpWm0drRJBEIShmXxNcqylaxGUHlroLeRjgr1Mt93dgzf_Df89_xLfm8wuO_TgxesmC0ne1y-T936PkA8dxGCuMq9TI-CCwr2sg0Yi11YnoVhWPGNx8rfv-vJGfr1Vt1utvjAnrNADl4M7TbBV39goAqYkShkSAPQ26ibIDOC-1JEzu75Mje8HoIZ8fMNsjD5dYFTDm7OtOSDkWk6i0EDW_9Qlb8Wkab7kVgCaPSMHI3KkZ2XFz8lO1x-S_fLZjZZqohekn5X-OdSPx94lip9a6bpo-8-v3wtaih9p9hEzY39SLDBfLijgVzpH9omHFWBPuslBp3c9fUR6Dnrl5ytPwTHSLzjFvyQ3s4vr88t6bKlQR4A2S3wANqzNLLEYlRUeL3y6zUpxk7gWIQRADNl0PkuNraoECxkglWfSR4OtYY7Ibn_fd68IZam1PNvEfLIgFQm4xnqjDPNI4pVMRT6tj9jNC3OGG24cRrsiDwfycCgPJyvyGYWwmYik18MPoApuVAX3L1WoyEcUoUPTBDlFP1YYwHqR5MqdKQN4FznkK3IymQkmFafDayVwo0kvHLh2IbnUAhb7fjOM_8Q0tb67X-EcIxUS1rOKHBed2WwJnKnRxjYVaSfaNNnzdKS_-zEQfoOPFLxVr__HIb0hexztAKvy2QnZXT6uureAq5bh3WBCfwFv8h-q priority: 102 providerName: Directory of Open Access Journals – databaseName: AUTh Library subscriptions: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1fi9QwEB9070FBRM9_1VMiCIJQLk2TNH2SO7n1EDwO8eDeQto0ei_dve3ug29-Db-en8SZNq1XBF83Wbbd-febZOY3AG8ajMFCBZH6LMcERTiZVpqIXAvtc8WDEoGakz-f6dML-elSXcYDty6WVY4-sXfUflXTGfkhWlYuhdS5fL--TmlqFN2uxhEat2FPYKYgFrB3fHJ2_mW6R0B1FPEuMzP6sKPoRhl0mQpEyqmcRaOetP9f13wjNs3rJm8EouUDuB8RJDsaRP4QbjXtPtwZG4y7fbg3HMWxocPoEbTLYaYOc1EUjWd0_MrGRu7fP391bGiIZMHVVC37g1HT-bZjiGnZmhgprneIR9lUl86uWrYhyg527tY7x9BZso-0xT2Gi-XJ1w-naRyzkNYId7Z0KWx4Ebjnda3K3FESqIuglDBe6LyqKkQRwTQuSE3jq3JeBYRZjktXGxoX8wQW7aptngHjvihFKD13vpSVl4h1SmeU4Y6IvbxJ4N34d9v1wKZh-yzEaDvIxqJsLMnGygSOSSDTRiLC7j9Ybb7ZaFfWoyW4rKzziipWJf4o5m9FrbNKBsz9igTekjgtmSvKrHax6wCfl4iv7JEyiIGJVz6Bg9lONLN6vjwqhI1m3tm_SpnA62mZvkmla22z2tEeIxWR2PMEng76M70SOlijTZklUMw0a_bO85X26ntPAo5-MxeFev7_x3oBdwVpO_Xg8wNYbDe75iWiqG31KprKH3nzHCQ priority: 102 providerName: ProQuest – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LaxRBEC5ivAgivh2N0oIgCKO9_Zqeg0gSXIOgeHAht6Z7ejoGZHazDzA3_4Z_L78kVfNYM5iL1-nanZmu93TVVwCvavTBQieRx4nEBEV4lQdDQK6FiVLzpEWi5uQvX83RTH0-1sc7MIy36jdwdW1qR_OkZsufb3-dnX9AhX_fKrw171bksygvLnOB8W-ubsBNQbhcVMmn_h4qoGy2h58KaTBR0P0h57V_MXJTLZr_vzb7itMaF1Re8VDTu3CnDy3ZficL92Cnbu7D7e67HOvajR5AM-0G7DDf86WOjL7FsqGr--L3nxXruiNZ8hWVzp4z6kBfrxgGuGxB8BRnGwxO2bZInZ02bEn4HeybX2w8Q8vJPhGJfwiz6cfvh0d5P3MhrzD2WdMJseVF4pFXlS6lp4zQFElrYaMwMoSAIUWytU_K0CwryUPCmMtz5StLs2MewW4zb-onwHgsSpHKyH0sVYgKA5_SW225J5SvaDN4M2yxW3TQGq5NSaxxHT8c8sMRP5zK4ICYsCUkVOz2wnx54nolcxHVwk_KSgYqX1V4U0zmispMgkqYCBYZvCYWOpIm5FPl-xYEfF5CwXL72mJATCDzGeyNKFHnqvHyIARuEFmHtl8qoYzEh325XaZfUh1bU883RGOVJkR7nsHjTma2r4TW1hpbTjIoRtI0eufxSnP6o0UERyMqRaGf_s-OPoNbguSd2vP5Huyul5v6OQZY6_CiVZtLfrIfnw priority: 102 providerName: Scholars Portal |
Title | Factors associated with children's health facility visits for primaquine treatment in rural Papua New Guinea |
URI | https://www.ncbi.nlm.nih.gov/pubmed/30786891 https://www.proquest.com/docview/2193424634 https://search.proquest.com/docview/2184535580 https://pubmed.ncbi.nlm.nih.gov/PMC6383275 https://doaj.org/article/deada19c3b014144bd9667c61b4f4957 |
Volume | 18 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBZJeimU0nfdposKhULBWVmWZPmYLNmGwoalNLA3oYfVLjTe7T4OvfVv9O_1l3TGjyWmt158sGQse76RZqSZbwh5V8EazGXkachycFC4FalTSORaqJBLFiWPmJw8u1ZXN-LTQi6OiOxzYZqgfe-WZ_X327N6-a2JrVzf-nEfJzaezyaAmZwXcnxMjgGgvYveHR0AAnl3fJlpNd7igoZOc5lyMI5TLMQDuNZKl9lgLWoo-_-dmO-sTMOoyTvL0PQRedjZj_S8HedjclTVT8iDdvONtjlFT0k9bavoUNv9_CpQ3HClfer2n1-_t7RNgaTReoyP_UkxzXy3pWDF0jVyUPzYgwVKD5HodFnTDZJ00Lld7y2F6ZF-xC72GbmZXn6ZXKVdYYXUg4Gzw2NgzYrIAvNelrlFt08VUUquA1e5cw7shqgrG4XCglU5cxEMK8uE9RoLxDwnJ_Wqrl4SykJR8lgGZkMpXBBg3ZRWS80sUnkFnZAP_S8265Y_wzR-h1amFY0B0RgUjREJuUAhHDoi9XVzY7X5ajoAmADYt1npc4cxqgJeCh5b4VXmRARvr0jIexShQQUFOXnb5RnAeJHqypxLDVYvMskn5HTQExTLD5t7EJhOsbcGJvhccKFyGOzbQzM-icFqdbXaYx8tJNLWs4S8aDFz-KQeegkpBmgafPOwBbSgof3uUP_qv598Te5z1ANMyGen5GS32VdvwKTauREo0qKAq55kI3Lv4vJ6_nnUbE_AdSb0qFGxvycGJTI |
link.rule.ids | 230,315,730,783,787,867,888,2109,12070,12237,21402,24332,27938,27939,31733,31734,33280,33281,33758,33759,43324,43593,43819,53806,53808 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1fb9MwED_B9jCkCcH4FxhgJCQkpGiOYzvOE9rQSoGtmtAm7c1y4hj2knZN-7A3vgZfj0_CXeOWRUi81q6a9P79zr77HcDbBmOwUEGkPssxQRFOppUmItdC-1zxoESg5uTTiR5fyC-X6jIeuHWxrHLtE1eO2k9rOiM_QMvKpZA6lx9m1ylNjaLb1ThC4y5sE1UVavX20fHk7NvmHgHVUcS7zMzog46iG2XQZSoQKadyEI1WpP3_uuZbsWlYN3krEI0ewP2IINlhL_KHcKdp92Bn3WDc7cFufxTH-g6jR9CO-pk6zEVRNJ7R8StbN3L__vmrY31DJAuupmrZG0ZN54uOIaZlM2KkuF4iHmWbunR21bI5UXawMzdbOobOkn2iLe4xXIyOzz-O0zhmIa0R7izoUtjwInDP61qVuaMkUBdBKWG80HlVVYgigmlckJrGV-W8CgizHJeuNjQu5glstdO2eQaM-6IUofTc-VJWXiLWKZ1Rhjsi9vImgffrv9vOejYNu8pCjLa9bCzKxpJsrEzgiASy2UhE2KsPpvPvNtqV9WgJLivrvKKKVYk_ivlbUeuskgFzvyKBdyROS-aKMqtd7DrA5yXiK3uoDGJg4pVPYH-wE82sHi6vFcJGM-_sX6VM4M1mmb5JpWttM13SHiMVkdjzBJ72-rN5JXSwRpsyS6AYaNbgnYcr7dWPFQk4-s1cFOr5_x_rNeyMz09P7MnnydcXcE-Q5lM_Pt-HrcV82bxERLWoXkWz-QMfIh8e |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELagSAip4v0IFDASEhJSdr2O7TjHUljKo9UeqFRxsfyIYVWaXfZxgBN_g7_HL2Emj9UGbr3GjhJnvvHMxDPfEPK8BBvMZeRpGGUQoHArUqeQyDVXIZMsSh6xOPnoWB2eiPen8nSr1VedtO_ddFB9Ox9U0691buX83A-7PLHh5OgAMJPxXA7nIQ4vkyugs0x3gXp7gAA45O0h5kir4RLNGobORcrBRU6xHQ-gWytdjHoWqSbu_3973rJP_dzJLWM0vkE-d8toclDOBuuVG_if_zA8XmidN8n11kWl-82UW-RSWd0mu83_PdqULd0h1bhp1ENtK98yUPynS7vq8D-_fi9pU2VJo_WYgvuDYiX7aknBUaZzpLn4vgYnl26S3em0ogvkAaETO19bCjswfYtT7F1yMn7z6eAwbXs3pB58qBWeNGuWRxaY97LILEaWKo9Sch24ypxz4JpEXdooFPbEypiL4LtZJqzX2IPmHtmpZlX5gFAW8oLHIjAbCuGCAAeqsFpqZpEtLOiEvOzkZ-YNRYepQxutTCN3A3I3KHcjEvIKJbyZiOza9YXZ4otpv70JoF52VPjMYRqsgIdCUJh7NXIiQkCZJ-QF4sPgHgAg8LYtZYD3RTYtsy81ONZIVp-Qvd5M0F3fH-4QZtq9Y2nAhmSCC5XByz7bDOOdmA9XlbM1ztFCIjM-S8j9BpCbJXW4Tkjeg2pvzf0RAGDNLN4C7uGF73xKrk5ej83Hd8cfHpFrHPUNy__ZHtlZLdblY3DgVu5Jrap_AV6dRI8 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Factors+associated+with+children%E2%80%99s+health+facility+visits+for+primaquine+treatment+in+rural+Papua+New+Guinea&rft.jtitle=Malaria+journal&rft.au=Yoshii%2C+Akiko&rft.au=Sekihara%2C+Makoto&rft.au=Furusawa%2C+Takuro&rft.au=Hombhanje%2C+Francis&rft.date=2019-02-20&rft.issn=1475-2875&rft.eissn=1475-2875&rft.volume=18&rft.issue=1&rft_id=info:doi/10.1186%2Fs12936-019-2675-4&rft.externalDBID=n%2Fa&rft.externalDocID=10_1186_s12936_019_2675_4 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1475-2875&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1475-2875&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1475-2875&client=summon |